Atrás
Rango del Día
$3.43
$3.68
Rango de 52 Semanas
$1.64
$5.63
Volumen
11,794,990
Promedio 50D / 200D
$3.20
/
$2.53
Cierre Anterior
$3.63
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -3.1 | 0.3 |
| P/B | 1.7 | 2.9 |
| ROE % | -55.5 | 3.7 |
| Net Margin % | -148.4 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$2.00
-44.8%
EPS Futuro
-$0.50
Ingresos Est.
380 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$0.22
$0.18 – $0.27
|
870 M | 2 |
| FY2029 |
$0.10
$0.08 – $0.13
|
790 M | 4 |
| FY2028 |
$0.01
-$0.11 – $0.19
|
740 M | 6 |
Puntos Clave
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -336.24M
PEG of 0.17 suggests growth is underpriced
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)60.60%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-55.50%
ROIC-40.50%
Net Margin-148.38%
Op. Margin-153.08%
Seguridad
Debt / Equity
0.07
Current Ratio3.20
Interest Coverage0.00
Valoración
P/E Ratio
-3.07
P/B Ratio1.72
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 60.60% | Revenue Growth (3Y) | 1388.68% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 263.50M | Net Income (TTM) | -390.98M |
| ROE | -55.50% | ROA | -42.82% |
| Gross Margin | 97.23% | Operating Margin | -153.08% |
| Net Margin | -148.38% | Free Cash Flow (TTM) | -336.24M |
| ROIC | -40.50% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 3.20 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -3.07 | P/B Ratio | 1.72 |
| P/S Ratio | 4.56 | PEG Ratio | 0.17 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.20B | Enterprise Value | 1.09B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 263.50M | 164.07M | 1.19M | 0.0 | 0.0 |
| Net Income | -390.98M | -372.18M | -444.04M | -395.89M | -342.25M |
| EPS (Diluted) | -1.09 | -1.28 | -1.89 | -2.49 | -2.23 |
| Gross Profit | 256.22M | 40.08M | -9.57M | 0.0 | 0.0 |
| Operating Income | -403.36M | -395.28M | -460.56M | -398.88M | -342.70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 913.17M | 910.43M | 780.35M | 663.98M | 777.33M |
| Total Liabilities | 214.59M | 200.02M | 195.74M | 164.34M | 155.67M |
| Shareholders' Equity | 698.58M | 710.41M | 584.61M | 499.64M | 621.66M |
| Total Debt | 48.44M | 58.26M | 75.86M | 85.45M | 71.53M |
| Cash & Equivalents | 163.08M | 115.69M | 114.89M | 231.73M | 78.23M |
| Current Assets | 442.69M | 457.02M | 307.85M | 479.12M | 507.96M |
| Current Liabilities | 138.36M | 122.34M | 110.31M | 91.49M | 89.20M |